We are live on ! Find out more
TRIL

Trillium Therapeutics Inc.
TRIL

Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

65 hedge funds and large institutions have $244M invested in Trillium Therapeutics Inc. in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,673% more capital invested

Capital invested by funds: $8.81M → $244M (+$235M)

1,600% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 3

242% more funds holding

Funds holding: 19 → 65 (+46)

149% more call options, than puts

Call options by funds: $2.08M | Put options by funds: $836K

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

Holders
65
Holders Change
+46
Holders Change %
+242.11%
% of All Funds
1.43%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
51
Increased
9
Reduced
5
Closed
3
Calls
$2.08M
Puts
$836K
Net Calls
+$1.25M
Net Calls Change
+$1.24M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$24M
2
ACA
Avoro Capital Advisors
New York
+$18.7M
3
BC
Boxer Capital
California
+$15.4M
4
NMC
NEA Management Company
Maryland
+$13.7M
5
Citadel Advisors
Citadel Advisors
Florida
+$13M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$8.82M
2
Morgan Stanley
Morgan Stanley
New York
-$6.35M
3
BBA
Baker Bros. Advisors
New York
-$1.13M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$323K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$49.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
26
Sio Capital Management
New York
$1.69M -$8.82M -2,333,609 -85%
Balyasny Asset Management
27
Balyasny Asset Management
Illinois
$1.32M +$1.23M +326,065 New
Two Sigma Advisers
28
Two Sigma Advisers
New York
$1.29M +$1.1M +291,100 +1,014%
EC
29
EcoR1 Capital
California
$1.18M +$1.1M +291,997 New
SM
30
Sabby Management
Florida
$1.16M +$1.09M +287,906 New
JP Morgan Chase
31
JP Morgan Chase
New York
$1.01M +$950K +251,272 New
Morgan Stanley
32
Morgan Stanley
New York
$764K -$6.35M -1,681,078 -90%
Bank of America
33
Bank of America
North Carolina
$711K +$658K +174,042 +8,702%
SSA
34
Schonfeld Strategic Advisors
New York
$687K +$643K +170,000 New
DMK
35
David M. Knott
$551K +$516K +136,500 New
Barclays
36
Barclays
United Kingdom
$530K +$496K +131,170 New
Goldman Sachs
37
Goldman Sachs
New York
$455K +$426K +112,651 New
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$448K +$419K +110,886 New
PVI
39
Pura Vida Investments
New York
$390K +$365K +96,487 New
FIA
40
FNY Investment Advisers
New York
$343K +$321K +85,000 New
RIA
41
Realta Investment Advisors
Delaware
$173K +$95.4K +25,250 +144%
LPL Financial
42
LPL Financial
California
$171K +$113K +29,825 +236%
FAM
43
Fred Alger Management
New York
$162K +$151K +40,000 New
GC
44
Gratus Capital
Georgia
$162K +$151K +40,000 New
ECM
45
ExodusPoint Capital Management
New York
$141K +$132K +35,000 New
Jane Street
46
Jane Street
New York
$124K +$11K +2,917 +10%
PP
47
Paloma Partners
Connecticut
$120K +$114K +30,200 New
QSS
48
Quantitative Systematic Strategies
Florida
$73K +$68.5K +18,109 New
Geode Capital Management
49
Geode Capital Management
Massachusetts
$69K -$323K -85,477 -83%
FDCDDQ
50
Federation des caisses Desjardins du Quebec
Quebec, Canada
$66.5K -$49.1K -13,000 -43%
1
2
3

TRIL Hedge Fund Activity: Q1 2020 in Review

65 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Trillium Therapeutics Inc. (TRIL) for Q1 2020, worth a combined $244M — up 2,673% from $8.81M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new TRIL positions and 3 closed out — a net gain of 48 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $24M. The largest seller was Sio Capital Management, cutting an estimated $8.82M.

  • 65 institutional investors held Trillium Therapeutics Inc. (TRIL) as of Q1 2020, up from 19 in Q4 2019.
  • Funds reported $244M of Trillium Therapeutics Inc. stock for Q1 2020, up 2,673% quarter-over-quarter.
  • 51 funds opened new Trillium Therapeutics Inc. positions in Q1 2020 and 3 closed out, a net change of +48 holders.
  • The largest Trillium Therapeutics Inc. buyer in Q1 2020 was RA Capital Management, an estimated $24M added.
  • The largest Trillium Therapeutics Inc. seller in Q1 2020 was Sio Capital Management, an estimated $8.82M sold.

Based on aggregated 13F filings for Q1 2020.